Medicating Childhood Anxiety: What the FDA's Approval of Escitalopram for Kids Really Tells Us About Risk, Evidence, and Trust

Psychology Tidbits by Circle Of Insight Productions

In 2023 the FDA approved escitalopram, sold as Lexapro, for generalized anxiety disorder in children as young as seven, a decision resting largely on a single industry-sponsored trial that showed only a modest statistica...View more